Guardian Financial Partners LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Guardian Financial Partners LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,466 shares of the medical equipment provider’s stock after acquiring an additional 26 shares during the quarter. Guardian Financial Partners LLC’s holdings in Intuitive Surgical were worth $765,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in ISRG. State Street Corp raised its stake in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares during the last quarter. FMR LLC increased its stake in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the period. Geode Capital Management LLC increased its stake in shares of Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after buying an additional 143,440 shares during the period. Fisher Asset Management LLC lifted its stake in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after acquiring an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. boosted its holdings in Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $582.01 on Thursday. The stock has a market capitalization of $207.30 billion, a PE ratio of 93.57, a P/E/G ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $355.17 and a 1-year high of $584.60. The business has a 50 day simple moving average of $537.05 and a two-hundred day simple moving average of $496.50.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 in the last three months. Insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on ISRG shares. Raymond James boosted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Wells Fargo & Company upped their price target on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Royal Bank of Canada boosted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.